Is heart failure the critical warning sign for death following myocardial infarction?

European Heart Journal

Volumn 29, Issue 7, 2008, Pages 833-834

  Møller, Jacob E ^a   Torp Pedersen, Christian ^a   Køber, Lars V ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR RISK; CLINICAL FEATURE; DIABETES MELLITUS; DISEASE COURSE; EDITORIAL; FOLLOW UP; HEART DEATH; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; PRIORITY JOURNAL; PROGNOSIS; QRS COMPLEX; RISK ASSESSMENT; RISK FACTOR;

HEART FAILURE; HUMANS; MYOCARDIAL INFARCTION; PROGNOSIS; RISK FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 41849093683     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehn067     Document Type: Editorial

References (6)

1. Torabi A, Cleland JGF, Khan NK, Loh PH, Clark AL, Alamgir F, Caplin JL, Rigby AS, Goode K. The timing of development and subsequent clinical course of heart failure after a myocardial infarction. Eur Heart J 2008;29:859-870. First published on March 19, 2008. doi:10.1093/ eurheartj/ehn096.
2. Yan RT, White M, Yan AT, Yusuf S, Rouleau JL, Maggioni AP, Hall C, Latini R, Afzal R, Floras J, Masson S, McKelvie RS. Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Investigators. Usefulness of temporal changes in neurohormones as markers of ventricular remodeling and prognosis in patients with left ventricular systolic dysfunction and heart failure receiving either candesartan or enalapril or both. Am J Cardiol 2005;96:698-704.
3. Temporelli PL, Giannuzzi P, Nicolosi GL, Giannuzzi P, Bosimini E, Gentile F, Maggioni AP, Tavazzi L, Piazza R, Ascione L, Stoian I, Cervesato E, Popescu AC, Nicolosi GL; GISSI-3 Echo Substudy Investigators. Doppler-derived mitral deceleration time as a strong prognostic marker of left ventricular remodeling and survival after acute myocardial infarction: results of the GISSI-3 echo substudy. J Am Coll Cardiol 2004;43:1646-1653.
4. Temporelli PL, Corra U, Imparato A, Bosimini E, Scapellato F, Giannuzzi P. Reversible restrictive left ventricular diastolic filling with optimized oral therapy predicts a more favorable prognosis in patients with chronic heart failure. J Am Coll Cardiol 1998;31:1591-1597.
5. Anand IS, Fisher LD, Chiang YT, Latini R, Masson S, Maggioni AP, Glazer RD, Tognoni G, Cohn JN; for the Val-HeFT Investigators. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the valsartan heart failure trial (Val-HeFT). Circulation 2003;107:1278-1283.
6. Buch P, Rasmussen S, Gislason GH, Rasmussen JN, Friberg J, Køber L, Gadsbøll N, Stender S, Madsen M, Torp-Pedersen C, Abildstrom SZ. Temporal decline in the prognostic impact of a recurrent acute myocardial infarction 1985 to 2002. Heart 2007;93:210-215.